Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-07-12 00:00:00 ET · period of report 2021-07-09 · accession 0001219036-21-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-12 | 2021-07-09 | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $32.62 | -50.0K | 232.6K | -18% | -$1.63M |
| DM | 2021-07-12 | 2021-07-09 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $24.01 | +50.0K | 259.3K | +24% | +$1.20M |
| DM | 2021-07-12 | 2021-07-09 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $0.00 | -50.0K | 109.5K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-09 | S | D | 17,692 | $32.47 | 232,550 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-09 | M | A | 17,692 | $19.47 | 250,242 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-09 | M | A | 5,603 | $26.49 | 238,153 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-09 | S | D | 26,705 | $32.79 | 232,550 | D | — | — | |
| 5 | Common | Common Stock | 2021-07-09 | M | A | 26,705 | $26.49 | 259,255 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-09 | S | D | 5,603 | $32.29 | 232,550 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-09 | M | D | 26,705 | $0.00 | 115,123 | D | $26.49 · — to 2021-09-17 | 26,705 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-09 | M | D | 17,692 | $0.00 | 0 | D | $19.47 · — to 2021-09-13 | 17,692 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-09 | M | D | 5,603 | $0.00 | 109,520 | D | $26.49 · — to 2021-09-17 | 5,603 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |